Non-uniform biological aging: findings from the Hebrew University of Jerusalem
BiologyComments
The jump to targeted cancer treatments seems a bit fast. In a clinical setting, how do you actually target a specific cluster of old cells without hitting the healthy ones right next to them?
Why focus on the delivery? The real story is that biological age has been a marketing term for supplements for years. Now we have actual data showing it's a mosaic, not a single number.
To your point on targeting, I wonder if the researchers analyzed the secretory phenotype of these aged cells. Specifically, are the senescence-associated secretory phenotype (SASP) factors driving the aging of neighboring cells?
This feels like a rebranding of the epigenetic clock research from a few years back. We've seen these markers fluctuate based on short-term lifestyle changes, which complicates the idea of a fixed cellular age.
similar to how we found mosaicism in genomic sequences.
This could be a huge win for organ transplants. If we can screen donor organs for specific cellular senescence levels, we might significantly reduce rejection rates in older recipients.